Gene · 4320
Papers3,235
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,235
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Identification and validation of biomarkers for epithelial-mesenchymal transition-related cells to estimate the prognosis and immune microenvironment in primary gastric cancer by the integrated analysis of single-cell and bulk RNA sequencing data. | Math Biosci Eng | 2023 | 37679111 | PubTator, text mining | PubMed |
| The role of non-coding RNAs in extracellular vesicles in breast cancer and their diagnostic implications. | Oncogene | 2023 | 37670020 | PubTator, text mining | PubMed |
| Functionally distinct cancer-associated fibroblast subpopulations establish a tumor promoting environment in squamous cell carcinoma. | Nat Commun | 2023 | 37669956 | PubTator, text mining | PubMed |
| Molecular basis of RNA-binding and autoregulation by the cancer-associated splicing factor RBM39. | Nat Commun | 2023 | 37666821 | PubTator, text mining | PubMed |
| Stromal cells in the tumor microenvironment: accomplices of tumor progression? | Cell Death Dis | 2023 | 37666813 | PubTator, text mining | PubMed |
| Extracellular vesicles in gastric cancer: role of exosomal lncRNA and microRNA as diagnostic and therapeutic targets. | Front Physiol | 2023 | 37664422 | PubTator, text mining | PubMed |
| An anoikis-related gene signature for prediction of the prognosis in prostate cancer. | Front Oncol | 2023 | 37664042 | PubTator, text mining | PubMed |
| Inhibition of PPARγ by BZ26, a GW9662 derivate, attenuated obesity-related breast cancer progression by inhibiting the reprogramming of mature adipocytes into to cancer associate adipocyte-like cells. | Front Pharmacol | 2023 | 37649895 | PubTator, text mining | PubMed |
| Single-cell RNA reveals a tumorigenic microenvironment in the interface zone of human breast tumors. | Breast Cancer Res | 2023 | 37644609 | PubTator, text mining | PubMed |
| Matrix scaffolds for endometrium-derived organoid models. | Front Endocrinol (Lausanne) | 2023 | 37635971 | PubTator, text mining | PubMed |
| Skin Extracellular Matrix Breakdown Following Paclitaxel Therapy in Patients with Chemotherapy-Induced Peripheral Neuropathy. | Cancers (Basel) | 2023 | 37627219 | PubTator, text mining | PubMed |
Notch, SUMOylation, and ESR-Mediated Signalling Are the Main Molecular Pathways Showing Significantly Different Epimutation Scores between Expressing or Not Oestrogen Receptor Breast Cancer in Three Public EWAS Datasets. | Cancers (Basel) | 2023 | 37627137 | PubTator, text mining | PubMed |
| Medical Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer. | Biology (Basel) | 2023 | 37626931 | PubTator, text mining | PubMed |
| Novel CAF-identifiers via transcriptomic and protein level analysis in HNSC patients. | Sci Rep | 2023 | 37626157 | PubTator, text mining | PubMed |
| Crosstalk between Long Non-Coding RNA and Spliceosomal microRNA as a Novel Biomarker for Cancer. | Noncoding RNA | 2023 | 37624034 | PubTator, text mining | PubMed |
| An mRNA Profiling Study of Vaginal Swabs from Pre- and Postmenopausal Women. | Curr Issues Mol Biol | 2023 | 37623230 | PubTator, text mining | PubMed |
| Advances in single-cell RNA sequencing and its applications in cancer research. | J Hematol Oncol | 2023 | 37612741 | PubTator, text mining | PubMed |
| linc00511 Knockdown Inhibits Lung Cancer Progression by Regulating miR-16-5p/MMP11. | Crit Rev Eukaryot Gene Expr | 2023 | 37602450 | PubTator, text mining | PubMed |
| The Bladder Tumor Microenvironment Components That Modulate the Tumor and Impact Therapy. | Int J Mol Sci | 2023 | 37569686 | PubTator, text mining | PubMed |
| Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment. | Int J Mol Sci | 2023 | 37569509 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4320/papers?page=13